Skip to main content

Advertisement

Log in

Left atrial volume and function measured by cardiac magnetic resonance imaging as predictors of shocks and mortality in patients with implantable cardioverter-defibrillators

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

Left atrial (LA) volume and function (LA ejection fraction, LAEF) have demonstrated prognostic value in various cardiovascular diseases. We investigated the incremental value of LA volume and LAEF as measured by cardiovascular magnetic resonance imaging (CMR) for prediction of appropriate implantable cardioverter defibrillator (ICD) shock or all-cause mortality, in patients with ICD. We conducted a retrospective, multi-centre observational cohort study of patients who underwent CMR prior to primary or secondary prevention ICD implantation. A single, blinded reader measured maximum LA volume index (maxLAVi), minimum LA volume index (minLAVi), and LAEF. The primary outcome was a composite of independently adjudicated appropriate ICD shock or all-cause death. A total of 392 patients were enrolled. During a median follow-up time of 61 months, 140 (35.7%) experienced an appropriate ICD shock or died. Higher maxLAVi and minLAVi, and lower LAEF were associated with greater risk of appropriate ICD shock or death in univariate analysis. However, in multivariable analysis, LAEF (HR 0.92 per 10% higher, 95% CI 0.81–1.04, p = 0.17) and maxLAVi (HR 1.02 per 10 ml/m2 higher, 95% CI 0.93–1.12, p = 0.72) were not independent predictors of the primary outcome. In conclusion, LA volume and function measured by CMR were univariate but not independent predictors of appropriate ICD shocks or mortality. These findings do not support the routine assessment of LA volume and function to refine risk stratification to guide ICD implant. Larger studies with longer follow-up are required to further delineate the clinical implications of LA size and function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

Data available upon request.

References

  1. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB et al (2018) 2017 AHA/ACC/HRS 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart Rhythm society. J Am Coll Cardiol 72(14):1677–1749. https://doi.org/10.1016/j.jacc.2017.10.053

    Article  PubMed  Google Scholar 

  2. Goldberger JJ, Subacius H, Patel T, Cunnane R, Kadish AH (2014) Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol 63(18):1879–1889. https://doi.org/10.1016/j.jacc.2013.12.021

    Article  PubMed  Google Scholar 

  3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352(3):225–237. https://doi.org/10.1056/NEJMoa043399

    Article  CAS  PubMed  Google Scholar 

  4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346(12):877–883. https://doi.org/10.1056/NEJMoa013474

    Article  PubMed  Google Scholar 

  5. Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C et al (2007) Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med 147(4):251–262. https://doi.org/10.7326/0003-4819-147-4-200708210-00007

    Article  PubMed  Google Scholar 

  6. Levy WC, Lee KL, Hellkamp AS, Poole JE, Mozaffarian D, Linker DT et al (2009) Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation 120(10):835–842. https://doi.org/10.1161/CIRCULATIONAHA.108.816884

    Article  PubMed  PubMed Central  Google Scholar 

  7. Sabbag A, Suleiman M, Laish-Farkash A, Samania N, Kazatsker M, Goldenberg I et al (2015) Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: from the Israeli ICD Registry. Heart Rhythm 12(12):2426–2433. https://doi.org/10.1016/j.hrthm.2015.08.020

    Article  PubMed  Google Scholar 

  8. Kober L, Thune JJ, Nielsen JC, Haarbo J, Videbaek L, Korup E et al (2016) DefibrillatorDefibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 375(13):1221–1230. https://doi.org/10.1056/NEJMoa1608029

    Article  PubMed  Google Scholar 

  9. Santangeli P, Dello Russo A, Casella M, Pelargonio G, Di Biase L, Natale A (2011) Left ventricular ejection fraction for the risk stratification of sudden cardiac death: friend or foe? Intern Med J 41(1a):55–60. https://doi.org/10.1111/j.1445-5994.2010.02371.x

    Article  CAS  PubMed  Google Scholar 

  10. Almehmadi F, Joncas SX, Nevis I, Zahrani M, Bokhari M, Stirrat J et al (2014) Prevalence of myocardial fibrosis patterns in patients with systolic dysfunction: prognostic significance for the prediction of sudden cardiac arrest or appropriate implantable cardiac defibrillator therapy. Circ Cardiovasc Imaging 7(4):593–600. https://doi.org/10.1161/CIRCIMAGING.113.001768

    Article  PubMed  Google Scholar 

  11. Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S et al (2013) Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309(9):896–908. https://doi.org/10.1001/jama.2013.1363

    Article  CAS  PubMed  Google Scholar 

  12. Haghbayan H, Lougheed N, Deva DP, Chan KKW, Lima JAC, Yan AT (2019) Peri-Infarct quantification by cardiac magnetic resonance to predict outcomes in ischemic cardiomyopathy: prognostic systematic review and meta-analysis. Circ Cardiovasc Imaging 12(11):e009156. https://doi.org/10.1161/CIRCIMAGING.119.009156

    Article  PubMed  Google Scholar 

  13. Hoit BD (2014) Left atrial size and function: role in prognosis. J Am Coll Cardiol 63(6):493–505. https://doi.org/10.1016/j.jacc.2013.10.055

    Article  PubMed  Google Scholar 

  14. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB (2002) Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 90(12):1284–1289. https://doi.org/10.1016/s0002-9149(02)02864-3

    Article  PubMed  Google Scholar 

  15. Appleton CP, Galloway JM, Gonzalez MS, Gaballa M, Basnight MA. Estimation of left ventricular filling pressures using two-dimensional and Doppler echocardiography in adult patients with cardiac disease. Additional value of analyzing left atrial size, left atrial ejection fraction and the difference in duration of pulmonary venous and mitral flow velocity at atrial contraction. J Am Coll Cardiol. 1993;22(7):1972–82. https://doi.org/10.1016/0735-1097(93)90787-2.

  16. Geske JB, Sorajja P, Nishimura RA, Ommen SR (2009) The relationship of left atrial volume and left atrial pressure in patients with hypertrophic cardiomyopathy: an echocardiographic and cardiac catheterization study. J Am Soc Echocardiogr 22(8):961–966. https://doi.org/10.1016/j.echo.2009.05.003

    Article  PubMed  Google Scholar 

  17. Guron CW, Hartford M, Rosengren A, Thelle D, Wallentin I, Caidahl K (2005) Usefulness of atrial size inequality as an indicator of abnormal left ventricular filling. Am J Cardiol 95(12):1448–1452. https://doi.org/10.1016/j.amjcard.2005.02.011

    Article  PubMed  Google Scholar 

  18. Lydell CP, Mikami Y, Homer K, Peng M, Cornhill A, Rajagopalan A et al (2019) Left atrial function using cardiovascular magnetic resonance imaging independently predicts life-threatening arrhythmias in patients referred to receive a primary prevention implantable cardioverter defibrillator. Can J Cardiol 35(9):1149–1157. https://doi.org/10.1016/j.cjca.2019.04.015

    Article  PubMed  Google Scholar 

  19. Rijnierse MT, Kamali Sadeghian M, Schuurmans Stekhoven S, Biesbroek PS, van der Lingen AC, van de Ven PM et al (2017) Usefulness of left atrial emptying fraction to predict ventricular arrhythmias in patients with implantable cardioverter defibrillators. Am J Cardiol 120(2):243–250. https://doi.org/10.1016/j.amjcard.2017.04.015

    Article  PubMed  Google Scholar 

  20. Ren JF, Kotler MN, DePace NL, Mintz GS, Kimbiris D, Kalman P et al (1983) Two-dimensional echocardiographic determination of left atrial emptying volume: a noninvasive index in quantifying the degree of nonrheumatic mitral regurgitation. J Am Coll Cardiol 2(4):729–736. https://doi.org/10.1016/s0735-1097(83)80313-1

    Article  CAS  PubMed  Google Scholar 

  21. Maceira AM, Prasad SK, Khan M, Pennell DJ (2006) Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 8(3):417–426

    Article  CAS  Google Scholar 

  22. Fatema K, Barnes ME, Bailey KR, Abhayaratna WP, Cha S, Seward JB, et al. Minimum vs. maximum left atrial volume for prediction of first atrial fibrillation or flutter in an elderly cohort: a prospective study. Eur J Echocardiogr. 2009;10(2):282–6. https://doi.org/10.1093/ejechocard/jen235.

  23. Habibi M, Samiei S, Ambale Venkatesh B, Opdahl A, Helle-Valle TM, Zareian M, et al. Cardiac magnetic resonance-measured left atrial volume and function and incident atrial fibrillation: results from MESA (Multi-Ethnic Study of Atherosclerosis). Circ Cardiovasc Imaging. 2016;9(8). https://doi.org/10.1161/CIRCIMAGING.115.004299.

  24. Pellicori P, Zhang J, Lukaschuk E, Joseph AC, Bourantas CV, Loh H et al (2015) Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value. Eur Heart J 36(12):733–742. https://doi.org/10.1093/eurheartj/ehu405

    Article  CAS  PubMed  Google Scholar 

  25. Huang JL, Tai CT, Lin YJ, Ting CT, Chen YT, Chang MS et al (2006) The mechanisms of an increased dominant frequency in the left atrial posterior wall during atrial fibrillation in acute atrial dilatation. J Cardiovasc Electrophysiol 17(2):178–188. https://doi.org/10.1111/j.1540-8167.2005.00297.x

    Article  PubMed  Google Scholar 

  26. Kayatas M, Ozdemir FN, Muderrisoglu H, Korkmaz ME (1999) Diastolic dysfunction increases the frequency of ventricular arrhythmia in hemodialysis patients. Nephron 82(2):185–187. https://doi.org/10.1159/000045398

    Article  CAS  PubMed  Google Scholar 

  27. Mordi I, Jhund PS, Gardner RS, Payne J, Carrick D, Berry C et al (2014) LGE and NT-proBNP identify low risk of death or arrhythmic events in patients with primary prevention ICDs. JACC Cardiovasc Imaging 7(6):561–569. https://doi.org/10.1016/j.jcmg.2013.12.014

    Article  PubMed  Google Scholar 

  28. Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European society of cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793–867. https://doi.org/10.1093/eurheartj/ehv316.

  29. Bellenger NG, Davies LC, Francis JM, Coats AJ, Pennell DJ (2000) Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2(4):271–278. https://doi.org/10.3109/10976640009148691

    Article  CAS  PubMed  Google Scholar 

  30. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU et al (2002) Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 90(1):29–34. https://doi.org/10.1016/s0002-9149(02)02381-0

    Article  PubMed  Google Scholar 

  31. Rodevan O, Bjornerheim R, Ljosland M, Maehle J, Smith HJ, Ihlen H (1999) Left atrial volumes assessed by three- and two-dimensional echocardiography compared to MRI estimates. Int J Card Imaging 15(5):397–410

    Article  CAS  Google Scholar 

  32. Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S (2005) Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 7(5):775–782. https://doi.org/10.1080/10976640500295516

    Article  PubMed  Google Scholar 

  33. Sievers B, Kirchberg S, Addo M, Bakan A, Brandts B, Trappe HJ (2004) Assessment of left atrial volumes in sinus rhythm and atrial fibrillation using the biplane area-length method and cardiovascular magnetic resonance imaging with TrueFISP. J Cardiovasc Magn Reson 6(4):855–863. https://doi.org/10.1081/jcmr-200036170

    Article  PubMed  Google Scholar 

  34. Jiamsripong P, Honda T, Reuss CS, Hurst RT, Chaliki HP, Grill DE et al (2008) Three methods for evaluation of left atrial volume. Eur J Echocardiogr 9(3):351–355. https://doi.org/10.1016/j.euje.2007.05.004

    Article  PubMed  Google Scholar 

Download references

Funding

No external funding has been obtained for this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew T. Yan.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Ethical approval

The study was approved by the Research Ethics Boards at study sites St. Michael’s Hospital and Sunnybrook Health Sciences Center in Toronto, Ontario, Canada.

Consent to participate

Informed consent was waived for this retrospective study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gong, I.Y., Yazdan-Ashoori, P., Jimenez-Juan, L. et al. Left atrial volume and function measured by cardiac magnetic resonance imaging as predictors of shocks and mortality in patients with implantable cardioverter-defibrillators. Int J Cardiovasc Imaging 37, 2259–2267 (2021). https://doi.org/10.1007/s10554-021-02196-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-021-02196-1

Keywords

Navigation